Greg Cobb
Directeur Général chez Sonoran Air, Inc.
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Richard L. Love | M | 81 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | - |
| Kevin J. Ontiveros | M | 63 |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | - |
| Rajan Ramaswami | M | - |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | 3 ans |
| Philip C. Ranker | M | 64 |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | 4 ans |
| Lynne E. Weissberger | M | - |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | - |
| John McCambridge | M | - |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | - |
| Walter Singleton | M | - |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | - |
| Bradford Zakes | M | 57 |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | 3 ans |
| John Moore | M | 59 |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 9 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
